A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

University of South Florida

Status and phase: Terminated; Phase 2

Conditions: Anorexia Nervosa

Treatments: Drug: quetiapine

Study type: Interventional

Funder types: Other

Identifiers

NCT00584688

0825

Details and patient eligibility

About

Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones known as dopamine and serotonin chemical systems in the brain.

Enrollment: 24 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must be aged 18-65
• Must be at least 15% below ideal body weight

Exclusion criteria

• Allergy to quetiapine
• Diagnosis of schizophrenia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Triple Blind